Back to search

Article

Therapeutic Targets for Multiple System Atrophy

2025-03-17

Abstract excerpt

<title>Abstract</title> <p> <bold>Background and Objectives:</bold> Multiple System Atrophy (MSA) is a progressive neurodegenerative disorder with no effective treatment. This research aims to identify novel potential therapeutic targets for MSA using systematic druggable genome-wide Mendelian Randomization (MR). <bold>Methods:</bold> The cis-expression quantitative trait locus information for drug-accessible...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
475cc3ff-d20a-554b-8cc0-44dd6f711024
DOI
10.21203/rs.3.rs-5873230/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Therapeutic Targets for Multiple System AtrophyDOI 10.21203/rs.3.rs-5873230/v1
Mendelian randomization and colocalization analysis reveal novel drug targets for myasthenia gravis.Semantic proximity
TBK1, a prioritized drug repurposing target for amyotrophic lateral sclerosis: evidence from druggable genome Mendelian randomization and pharmacological verification in vitroSemantic proximity
Multicomponent Mendelian randomization and machine learning studies of potential drug targets for neurodegenerative diseasesSemantic proximity
Identification of immune-mitophagy related gene in PD based on single-cell sequencing and Mendelian randomizationSemantic proximity
Regulatory Role of DDX17 in Immune-Autophagy Pathways of Parkinson’s Disease Revealed by Single-Cell and Genetic AnalysesSemantic proximity
Integrative multi-omics analysis identifies genetically supported druggable targets and immune cell specificity for myasthenia gravis.Semantic proximity
A network-based systems genetics framework identifies pathobiology and drug repurposing in Parkinson’s diseaseSemantic proximity
Identifying drug targets for neurological and psychiatric disease via genetics and the brain transcriptome.Semantic proximity
A systematic review and integrative approach to decode the common molecular link between levodopa response and Parkinson's disease.Semantic proximity
Nanomedicine for Neurodegenerative Disorders: Focus on Alzheimer’s and Parkinson’s DiseasesSemantic proximity
Integrating Genomic, eQTL, and Mendelian Randomization Analyses to Identify Microglial Drug Targets in Multiple Sclerosis.Semantic proximity
Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for sarcopenia.Semantic proximity
Select a neighboring publication to make it the new centre.